Hydroxyurea Compared With Anagrelide in High-Risk Essential Thrombocythemia
New England Journal of Medicine - United States
doi 10.1056/nejmoa043800
Full Text
Open PDFAbstract
Available in full text
Categories
Date
July 7, 2005
Authors
Publisher
Massachusetts Medical Society